يعرض 1 - 20 نتائج من 184 نتيجة بحث عن '"Schjesvold, Fredrik H"', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    Conference

    المصدر: Nielsen , L K , Möller , S , Rosenberg , T , Abildgaard , N , Nørgaard , J N & Schjesvold , F H 2024 , ' Carfilzomib-lenalidomide-dexamethasone consolidation after upfront autologous stemcell transplantation caused no significant patient-reported shortness of breath: Findings fromthe conpet study ' , HemaSphere , vol. 8 , no. Suppl. 1 , PB3420 , pp. 6317-6318 . < https://onlinelibrary.wiley.com/toc/25729241/2024/8/S1 >

  2. 2
    Academic Journal

    المصدر: Pawlyn , C , Schjesvold , F H , Cairns , D A , Wei , L J , Davies , F , Nadeem , O , Abdulhaq , H , Mateos , M V , Laubach , J , Weisel , K , Ludwig , H , Rajkumar , S V , Sonneveld , P , Jackson , G , Morgan , G & Richardson , P G 2024 , ' Progression-free survival as a surrogate endpoint in myeloma clinical trials : an evolving paradigm ' , Blood Cancer Journal , vol. 14 , no. 1 , 134 ....

    وصف الملف: application/pdf

  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المصدر: Schjesvold , F H , Ludwig , H , Mateos , M V , Larocca , A , Abdulhaq , H , Norin , S , Thuresson , M , Bakker , N A , Richardson , P G & Sonneveld , P 2024 , ' Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators : A subgroup analysis from the OCEAN study ' , European Journal of Haematology , vol. 112 , no. 3 , pp. 402-411 . https://doi.org/10.1111/ejh.14127

    وصف الملف: application/pdf

  5. 5
  6. 6
    Conference

    المصدر: MT , G , Schjesvold , F H , Vangsted , A J , Helleberg , C , Haukas , E , Silkjaer , T , Teodorescu , E M , Jensen , B A , Slordahl , T , Asmussen , J T , Nahi , H , Abildgaard , N & Lund , T 2023 , ' Four years treatment with Zoledronic Acid is superior to two years in protection against progressive bone disease in Multiple Myeloma ' , 20th International Myeloma Society Annual Meeting and Exposition , Athen , Greece , 27/09/2023 - 30/09/2023 . < ....

  7. 7
    Conference

    المصدر: MT , G , Schjesvold , F H , Vangsted , A J , Helleberg , C , Haukas , E , Silkjaer , T , Todorescu , E , Jensen , B A , Schmidt Slørdahl , T , Asmussen , J T , Nahi , H , Waage , A , Abildgaard , N & Lund , T 2023 , ' Treatment of patients with multiple myeloma with zoledronic acid for four years instead of two years decreases risk of progressive bone disease without increasing risk of osteonecrosis of the jaw ' , HemaSphere , vol. 7 ....

  8. 8
    Conference

    المصدر: Kongsgaard Nielsen , L , Möller , S , Schjesvold , F H , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , Abildgaard , N , Gregersen , H & King , M 2023 , ' Quality adjusted progression-free-period of Carfilzomib-dexamethasone maintenance therapy for patients with multiple myeloma treated for first relapse – findings from a Nordic Myeloma Study Group randomized phase II trial ' , Quality of Life Research , vol. 32 , no. Suppl. 2 , 309.2 , pp. 97 . < https://link.springer.com/article/10.1007/s11136-023-03530-x >

  9. 9
    Conference

    المصدر: Kongsgaard Nielsen , L , Schjesvold , F H , Möller , S , Guldbrandsen , N , Hansson , M , Remes , K , Peceliunas , V , Gregersen , H , King , M & Abildgaard , N 2023 , ' CARFILZOMIB-DEXAMETHASONE MAINTENANCE HAMPERS RECOVERY AFTER SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA ' , HemaSphere , vol. Abstract book , pp. 3245 . < https://journals.lww.com/hemasphere/Documents/EHA2023%20Abstract%20Book.pdf >

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Conference

    المصدر: MT , G , Asmussen , J T , Schjesvold , F H , Vangsted , A J , Helleberg , C , Haukas , E , Silkjaer , T , Teodorescu , E M , Jensen , B A , Schmidt Slørdahl , T , Nahi , H , Waage , A , Abildgaard , N & Lund , T 2022 , ' Regular monitoring with whole body low-dose CT for Osteolysis in Multiple Myeloma reveals more cases of progressive bone disease than imaging performed by clinical indication. ' , Clinical Lymphoma Myeloma and Leukemia , vol. 22 ....

  14. 14
    Conference

    المصدر: Nielsen , L K , Möller , S , Rosenberg , T , Abildgaard , N , Nørgaard , J N & Schjesvold , F H 2024 , ' Arfilzomib-lenalidomide-dexamethasone consolidation after upfront autologous stemcell transplantation caused no significant patient-reported shortness of breath: findings fromthe conpet study ' , EHA 2024 Hybrid Conference , Madrid , Spain , 13/06/2024 - 16/06/2024 .

  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Conference

    المصدر: MT , G , Abildgaard , N , Haukås , E , Schubert , M , Abildgaard , N , Schjesvold , F H & Lund , T 2021 , ' A prospective study of conventional skeletal survey versus Whole-body CT for osteolytic lesions in Multiple Myeloma ' , 18th International Myeloma Workshop , Vienna , Austria , 08/09/2021 - 11/09/2021 . < https://www.clinicalkey.com/#!/browse/toc/1-s2.0-S2152265021X00122/null/journalIssue >

  18. 18
    Academic Journal
  19. 19
    Academic Journal

    المساهمون: Emory University Atlanta, GA, Duke University Durham, University of Oslo (UiO), Integrative Oncogenomics of Multiple Myeloma Pathogenesis and Progression (CRCINA-ÉQUIPE 11), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Université d'Angers (UA), Université de Nantes (UN), Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Hôpital Claude Huriez Lille, Genentech, Inc. San Francisco, Abbvie Inc. North Chicago, AbbVie Deutschland GmbH & Co KG, Abbott GmbH & Co KG, Mayo Clinic Rochester, ANR-16-IDEX-0007,NExT (I-SITE),NExT (I-SITE)(2016)

    المصدر: ISSN: 0361-8609.

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

    Relation: info:eu-repo/semantics/altIdentifier/pmid/33368455; PUBMED: 33368455; PUBMEDCENTRAL: PMC7986778

  20. 20
    Academic Journal

    المصدر: 0939-5555.

    Relation: http://urn.nb.no/URN:NBN:no-88113; Kaiser, Martin Beksac, Meral Gulbrandsen, Nina Schjesvold, Fredrik H Hájek, Roman Moreau, Philippe de Arriba de la Fuente, Felipe Mateos, Maria-Victoria West, Sharon Spencer, Andrew Rajkumar, S. Vincent Suryanarayan, Kaveri Czorniak, Michael Li, Cong Teng, Zhaoyang Labotka, Richard Dimopoulos, Meletios A. . Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma. Annals of Hematology. 2020, 99(8), 1793-1804; http://hdl.handle.net/10852/85421; 1890060; info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Annals of Hematology&rft.volume=99&rft.spage=1793&rft.date=2020; Annals of Hematology; 99; 1793; 1804; https://doi.org/10.1007/s00277-020-04149-5; URN:NBN:no-88113; Fulltext https://www.duo.uio.no/bitstream/handle/10852/85421/1/Postnr%2B1890060_Kaiser2020_Article_AdverseEventManagementInTheTOU.pdf